Insider Transactions in Q2 2023 at Certara, Inc. (CERT)
Insider Transaction List (Q2 2023)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jun 30
2023
|
Robert Aspbury PRESIDENT, SCIENTIFIC SOFTWARE |
SELL
Payment of exercise price or tax liability
|
Direct |
862
-0.31%
|
$15,516
$18.19 P/Share
|
Jun 05
2023
|
Patrick F Smith PRESIDENT, DRUG DEV SOLUTIONS |
SELL
Open market or private sale
|
Direct |
19,104
-24.16%
|
$401,184
$21.55 P/Share
|
May 23
2023
|
Eran Broshy |
BUY
Exercise of conversion of derivative security
|
Direct |
9,360
+50.0%
|
-
|
May 23
2023
|
Rosemary A Crane |
BUY
Exercise of conversion of derivative security
|
Direct |
9,324
+50.0%
|
-
|
May 17
2023
|
Matthew M Walsh |
BUY
Exercise of conversion of derivative security
|
Direct |
9,067
+4.87%
|
-
|
May 17
2023
|
Cynthia Collins |
BUY
Exercise of conversion of derivative security
|
Direct |
9,067
+36.91%
|
-
|
May 17
2023
|
Nancy Killefer |
BUY
Exercise of conversion of derivative security
|
Direct |
9,067
+36.91%
|
-
|
May 17
2023
|
James E Cashman Iii |
BUY
Exercise of conversion of derivative security
|
Direct |
9,067
+1.98%
|
-
|
May 11
2023
|
Richard M. Traynor SVP AND GENERAL COUNSEL |
SELL
Open market or private sale
|
Direct |
5,000
-2.74%
|
$100,000
$20.82 P/Share
|
Apr 14
2023
|
Richard M. Traynor SVP AND GENERAL COUNSEL |
SELL
Open market or private sale
|
Direct |
5,000
-2.67%
|
$115,000
$23.66 P/Share
|